{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T13:28:27Z","timestamp":1795267707751,"version":"4.10.3"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamaophthalmol.2022.0059","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T11:33:22Z","timestamp":1646307202000},"page":"363","source":"Crossref","is-referenced-by-count":57,"title":["Safety and Efficacy of AGN-190584 in Individuals With Presbyopia"],"prefix":"10.1001","volume":"140","author":[{"suffix":"IV","given":"George O.","family":"Waring","sequence":"first","affiliation":[{"name":"Waring Vision Institute, Mt Pleasant, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Francis W.","family":"Price","sequence":"additional","affiliation":[{"name":"Price Vision Group, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wirta","sequence":"additional","affiliation":[{"name":"Eye Research Foundation, Newport Beach, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"McCabe","sequence":"additional","affiliation":[{"name":"The Eye Associates, Bradenton, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Moshirfar","sequence":"additional","affiliation":[{"name":"Hoopes Vision Research Center, Draper, Utah"},{"name":"John A. Moran Eye Center, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[{"name":"AbbVie Inc, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Gore","sequence":"additional","affiliation":[{"name":"AbbVie Inc, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[{"name":"AbbVie Inc, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Safyan","sequence":"additional","affiliation":[{"name":"AbbVie Inc, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Robinson","sequence":"additional","affiliation":[{"name":"AbbVie Inc, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"eoi220005r1","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","article-title":"Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: systematic review, meta-analysis, and modelling.","volume":"125","author":"Fricke","year":"2018","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi220005r2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40135-018-0190-3","article-title":"Characterization of the dysfunctional lens syndrome and a review of the literature.","volume":"6","author":"Waring","year":"2018","journal-title":"Curr Ophthalmol Rep."},{"issue":"S1","key":"eoi220005r3","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.3928\/1081597X-20210408-06","article-title":"Future trends in presbyopia correction.","volume":"37","author":"Mercer","year":"2021","journal-title":"J Refract Surg"},{"key":"eoi220005r4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ajo.2020.12.021","article-title":"Correlation of intraoperative optical coherence tomography of crystalline lens diameter, thickness, and volume with biometry and age.","volume":"225","author":"Waring","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"eoi220005r5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/OPTH","article-title":"Lens anatomy parameters with intraoperative spectral-domain optical coherence tomography in cataractous eyes.","volume":"13","author":"Haddad","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"eoi220005r6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1167\/iovs.02-0096","article-title":"Mechanical properties of the human posterior lens capsule.","volume":"44","author":"Krag","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi220005r7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1350-9462(03)00063-6","article-title":"Mechanical properties of the human lens capsule.","volume":"22","author":"Krag","year":"2003","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"eoi220005r8","first-page":"268","article-title":"Pathophysiology of accommodation and presbyopia: understanding the clinical implications.","volume":"81","author":"Schachar","year":"1994","journal-title":"J Fla Med Assoc"},{"key":"eoi220005r9","first-page":"79","article-title":"On the growth of the crystalline lens.","volume":"3","author":"Smith","year":"1883","journal-title":"Trans Ophthalmol Soc UK"},{"issue":"7","key":"eoi220005r10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ceo.2017.45.issue-7","article-title":"Impact of refractive error on quality of life: a qualitative study.","volume":"45","author":"Kandel","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"eoi220005r12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1046\/j.1532-5415.2002.50502.x","article-title":"Multifocal glasses impair edge-contrast sensitivity and depth perception and increase the risk of falls in older people.","volume":"50","author":"Lord","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"eoi220005r13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.preteyeres.2018.09.004","article-title":"Presbyopia: effectiveness of correction strategies.","volume":"68","author":"Wolffsohn","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"eoi220005r14","first-page":"25","article-title":"Presbyopia treatment with eye drops: an eight year retrospective study.","volume":"9","author":"Benozzi","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"eoi220005r15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40123-016-0050-x","article-title":"Pharmacological treatment of presbyopia by novel binocularly instilled eye drops: a pilot study.","volume":"5","author":"Renna","year":"2016","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"eoi220005r16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1167\/iovs.04-0990","article-title":"Comparisons between pharmacologically and Edinger-Westphal-stimulated accommodation in rhesus monkeys.","volume":"46","author":"Ostrin","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi220005r17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.exer.2010.02.005","article-title":"Topical and intravenous pilocarpine stimulated accommodation in anesthetized rhesus monkeys.","volume":"90","author":"Wendt","year":"2010","journal-title":"Exp Eye Res"},{"issue":"10","key":"eoi220005r18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5694\/mja2.1976.1.issue-10","article-title":"Headaches in relation to the eyes.","volume":"1","author":"Cameron","year":"1976","journal-title":"Med J Aust"},{"issue":"1","key":"eoi220005r19","first-page":"6","article-title":"Efficacy of topical pilocarpine in the management of primary aqueous tear deficiency: an initial study.","volume":"39","author":"Urriquia","year":"2014","journal-title":"Philipp J Ophthalmol"},{"key":"eoi220005r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100065","article-title":"Combinations of pilocarpine and oxymetazoline for the pharmacological treatment of presbyopia: two randomized phase 2 studies.","volume":"1","author":"Price","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"20","key":"eoi220005r22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"eoi220005r24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40123-021-00391-w","article-title":"Development of the Presbyopia Impact and Coping Questionnaire.","volume":"10","author":"Johnson","year":"2021","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"eoi220005r25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s41687-021-00378-y","article-title":"Development of the Near Vision Presbyopia Task-based Questionnaire for use in evaluating the impact of presbyopia.","volume":"5","author":"Shirneshan","year":"2021","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"eoi220005r28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEI\/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.","volume":"49","author":"Csaky","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"eoi220005r29","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.ophtha.2013.02.014","article-title":"Utility and uncorrected refractive error.","volume":"120","author":"Tahhan","year":"2013","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi220005r30","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1167\/iovs.10-6353","article-title":"Quality of life and near vision impairment due to functional presbyopia among rural Chinese adults.","volume":"52","author":"Lu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"eoi220005r31","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1167\/iovs.08-3294","article-title":"Impact of the severity of distance and near-vision impairment on depression and vision-specific quality of life in older people living in residential care.","volume":"50","author":"Lamoureux","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi220005r32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ophtha.2006.01.028","article-title":"Impact of presbyopia on quality of life in a rural African setting.","volume":"113","author":"Patel","year":"2006","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi220005r33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/archopht.121.11.1577","article-title":"Associations of presbyopia with vision-targeted health-related quality of life.","volume":"121","author":"McDonnell","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"eoi220005r35","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0149-2918(00)80008-9","article-title":"Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.","volume":"21","author":"Hartenbaum","year":"1999","journal-title":"Clin Ther"},{"issue":"8","key":"eoi220005r36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1755-3768.2008.01324.x","article-title":"Efficacy and safety of latanoprost versus pilocarpine\/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.","volume":"86","author":"Kaluzny","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"eoi220005r37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0149-2918(96)80042-7","article-title":"Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life.","volume":"18","author":"Laibovitz","year":"1996","journal-title":"Clin Ther"},{"issue":"8","key":"eoi220005r39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/bjo.52.8.607","article-title":"Influence of pH on the effect of pilocarpine on aqueous dynamics.","volume":"52","author":"Anderson","year":"1968","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi220005r40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/bjo.62.5.318","article-title":"Influence of pH on the efficacy of pilocarpine.","volume":"62","author":"David","year":"1978","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"eoi220005r41","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/bjo.60.8.568","article-title":"A comparison of the pupilloconstrictor effect of pilocarpine solution administered to the conjunctival sac as a single drop or as a continuous infusion in normal subjects.","volume":"60","author":"Birmingham","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"eoi220005r21","author":"Giyanani","year":"2020"},{"key":"eoi220005r27","author":"Evans","year":"2021"},{"key":"eoi220005r38","volume-title":"Glaucoma Update VI","author":"Nagasubramanian"},{"key":"eoi220005r11","unstructured":"American Optometric Association. Optometric clinical practice guideline: care of the patient with presbyopia. Revised December 2010. Accessed September 8, 2021. https:\/\/www.sdeyes.org\/docs\/CPG-17.pdf"},{"key":"eoi220005r23","unstructured":"National Eye Institute. National Eye Institute visual functioning questionnaire\u201325 (VFQ-25) version 2000. Published January 2000. Accessed October 12, 2021. https:\/\/www.nei.nih.gov\/sites\/default\/files\/2019-06\/vfq_ia.pdf"},{"key":"eoi220005r26","doi-asserted-by":"crossref","unstructured":"Schwiegerling? J. Field guide to visual and ophthalmic optics. SPIE. Published 2004. Accessed January 28, 2022. doi:10.1117\/3.592975","DOI":"10.1117\/3.592975"},{"key":"eoi220005r34","unstructured":"Institute for Quality and Efficiency in Health Care (IQWiG). How can presbyopia be corrected? Updated June 4, 2020. Accessed Aug 11, 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK423827\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2789627\/jamaophthalmology_waring_2022_oi_220005_1649949506.85907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:17:19Z","timestamp":1650539839000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2789627"}},"subtitle":["The GEMINI 1 Phase 3 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0059","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}